Back to search

Article

Membranous Nephropathy: Muti-omics Mendelian randomization and colocalization analysis

2023-11-22

Abstract excerpt

<h4>Background</h4> The currently available medications for treating membranous nephropathy (MN) still have unsatisfactory efficacy in inhibiting disease recurrence, slowing down its progression, and even halting the development of end-stage renal disease. There is still a need to develop novel drugs targeting MN. <h4>Methods</h4> We utilized summary statistics of MN from the Kiryluk Lab and obtained plasma protei...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c76f7246-166d-59b1-8a0a-1416f6fc75f3
DOI
10.1101/2023.11.21.23298831
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Membranous Nephropathy: Muti-omics Mendelian randomization and colocalization analysisDOI 10.1101/2023.11.21.23298831
Select a neighboring publication to make it the new centre.